Results

eNauka >  Rezultati >  Improvement in Patient-Reported Outcomes in Patients With Psoriatic Arthritis With Inadequate Response to Non-Biologic DMARDs Treated With Upadacitinib Versus Placebo or Adalimumab: Results From a Phase 3 Study
Naziv Improvement in Patient-Reported Outcomes in Patients With Psoriatic Arthritis With Inadequate Response to Non-Biologic DMARDs Treated With Upadacitinib Versus Placebo or Adalimumab: Results From a Phase 3 Study
Autori: Gladman, Dafna; Mease, Philip; Soriano, Enrique; Kishimoto, Mitsumasa; Salvarani, Carlo; Damjanov, Nemanja S; Anderson, Jaclyn K; Blondell, Erin; Zueger, Patrick; Saffore, Christopher;
Godina: 2021
Publikacija: JOURNAL OF RHEUMATOLOGY
ISSN: 0315-162X Journal of Rheumatology Pretraži identifikator
Tip rezultata: Konferencijski rad
Kolacija: vol. 48 br. 7 str. 1168-1168
WoS-ID: 000680554800186
URI: https://enauka.gov.rs/handle/123456789/827797
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

Find the DOI


Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.